AFP announces new bureau in North Korea
Agence France-Presse (AFP) announced Tuesday it will open a bureau in Pyongyang, becoming only the second global news agency to establish a permanent presence in the North Korean capital.
Paramaribo (AFP) | 06/07/2025 - 19:55:25 | Lawmakers elect Jennifer Geerlings-Simons as Suriname's first woman president
Rio de Janeiro (AFP) | 06/07/2025 - 19:21:56 | BRICS 'condemn the military strikes' against Iran: summit statement
Rio de Janeiro (AFP) | 06/07/2025 - 19:18:40 | BRICS call for 'unconditional' Gaza ceasefire: summit declaration
Rio de Janeiro (AFP) | 06/07/2025 - 19:14:26 | BRICS voice 'serious concerns' about Trump tariffs: summit statement
Jerusalem (AFP) | 06/07/2025 - 18:48:22 | Netanyahu says his meeting with Trump can 'help advance' Gaza deal
Rio de Janeiro (AFP) | 06/07/2025 - 16:44:10 | Hosting BRICS, Brazil's Lula hits out at 'genocide' in Gaza
Washington (AFP) | 06/07/2025 - 16:05:38 | New US tariff rates to kick in Aug 1 barring trade deals: Treasury Secretary
Hunt, Texas (AFP) | 06/07/2025 - 16:00:37 | Death toll in Texas flooding rises to 59: state official
Nairobi (AFP) | 06/07/2025 - 13:41:47 | Armed gang attacks Kenya Human Rights Commission: AFP
Jerusalem (AFP) | 06/07/2025 - 13:23:31 | Israeli delegation departs for Gaza talks in Doha: public broadcaster
Agence France-Presse (AFP) announced Tuesday it will open a bureau in Pyongyang, becoming only the second global news agency to establish a permanent presence in the North Korean capital.
AFP takes part to the 7th photography festival in Leipzig f/stop, Germany, from June 25th until July 3rd, 2016.
The Asian Productivity Organization (APO) convened the 67th Session of the Governing Body (GBM), 20–22 May 2025 in Jakarta, hosted by the Government of the Republic of Indonesia. This annual session brought together over 50 delegates representing APO member governments to discuss the APO’s strategic direction and ensure the organization’s continued credibility, effectiveness, and relevance amid a rapidly evolving productivity landscape. This press release features multimedia. View the full rel...
Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (Biocytogen, HKEX: 02315) today announced that the key technology of its independently developed RenMab™ fully human antibody mouse platform has been granted an invention patent by the Japan Patent Office (JPO). This milestone marks a significant step in strengthening the global intellectual property portfolio of the RenMice® fully human antibody platform family. It underscores the continued advancement of Biocytogen’s comprehensive ...